Comments
Pfizer, J&J scrap Alzheimer's studies as drug fails
07.08.2012. | NEW YORK (Reuters) - Pfizer Inc and Johnson & Johnson said they were scrapping further studies of one of the most anticipated experimental Alzheimer's disease treatments after the drug failed to help patients with the memory-robbing condition in a second high-profile late stage clinical trial....
